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Ali A. Hossaini (Transfusion Problems in Hemolytic Anemias) is associate
professor of clinical pathology and director of the blood bank at the Medical
College of Virginia. He completed his undergraduate studies at the American
University of Beirut, Lebanon, received his M.A. and M.S. degrees from Texas
Christian University, and earned his Ph.D. at Ohio State University. Before coming to MCV, Dr. Hossaini was on the faculty of the department of pathology at
West Virginia Medical Center in Morgantown.

Harold M. Maurer (New Concepts in Management of Neonatal Jaundice: Use
of Enzyme Induction and Phototherapy) is an assistant professor in the department of pediatrics at the Medical College of Virginia. Before coming to MCV,
he was chief of pediatrics at the U. S. Public Health Service Hospital in Norfolk,
Virginia, and then on the attending staff of Babies Hospital and Vanderbilt
Clinic, Columbia-Presbyterian Medical Center. Dr. Maurer received his M.D.
from the State University of New York, interned at Kings County Hospital in
Brooklyn, and trained in pediatrics at Babies Hospital.

Daniel N. Mohler ( Glucose-6-Phosphate Dehydrogenase Deficiency ) is associate
dean and professor of internal medicine at the University of Virginia School of
Medicine. He attended the University of Kentucky and Ohio State University,
then received his medical degree from the University of Virginia. After internship
at Massachusetts Memorial Hospitals and residency at U. Va., Dr. Mohler had
a research fellowship in hematology at the Washington University School of
Medicine, then returned to U . Va. where he has remained on the full-time staff
in medicine.

John H. Moon (lmmunosuppression in Autoimmune H emoly tic Anemia) is an

associate professor of medicine in the department of medicine at the Medical
College of Virginia. He attended the University of Richmond, then the Medical
College of Virginia where he received his medical degree. Dr. Moon interned at
Methodist Hospital, Indianapolis, and returned to do his residency at MCV,
where he has remained in the field of hematology.
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Robert I. Weed (New Thoughts on Hereditary Spherocytosis) is a professor of
medicine and of radiation biology and biophysics at the University of Rochester
School of Medicine and Dentistry; he is also head of the hematology unit. Dr.
Weed received his B.S. and M .D. from Yale University, interned at Strong
Memorial Hospital, and was an assistant resident in medicine at the Yale-New
Haven Medical Center. He held fellowships in hematology with the American
Cancer Society and the U .S. Public Health Service. Dr. Weed is also an associate
editor of Blood.

Wendell F. Rosse (Paroxysmal Nocturnal Hemoglobinuria-New Thoughts) is
associate professor of medicine and of immunology at Duke University. A graduate of the University of Omaha, he received his M.S. in physiology from the University of Nebraska and his M.D. from the University of Chicago. After internship and residency at Duke, Dr. Rosse was a clinical associate at the National
Cancer Institute, a fellow in hematology at the Postgraduate Medical School,
London, and a senior investigator at the National Cancer Institute. Dr. Rosse is
recipient of a Public Health Service Research Career Development Award.

M. Robert Cooper (The New Hemoglobinopathies) received his M.D. degree
from the Bowman-Gray School of Medicine of Wake Forest University. After
his internship at the University of Virginia Hospital, Dr. Cooper returned to
Bowman-Gray where he completed his residency in medicine, was a fellow in
clinical oncology, and is now assistant professor of medicine (hematology and
oncology). His primary research interests are in white cell metabolism, platelet
survival and sequestration, and viscosity changes in hemoglobinopathies.

Walter J. Geeraets (Solar Retinopathy Following the Eclipse of March 7, 1970:
A Follow Up), professor of ophthalmology and associate professor of biophysics
at the Medical College of Virginia, was born in M. Gladbach, Germany. He obtained a doctor's degree in medicine from the University of Bonn, later serving
as a research fellow at the Radiation Institute of that university and as the chief
assistant of the surgical clinics at Bochum, Germany. In 1957 he came to MCV
with appointments in the departments of ophthalmology and biophysics. Dr.
Geeraets is currently director of ophthalmic research and coordinator of the
NIH ophthalmic resident training program at MCV.
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